Anticonvulsant therapy in brain-tumor related epilepsy

Avila E.K., Graber J.:Seizures and epilepsy in cancer patients. Curr. Neurol. Neurosci. Rep., 2010, 10: 60–67.10.1007/s11910-009-0080-z20425228Search in Google Scholar

Bain E., Birhiray R.E., Reeves D.:Drug-drug interaction between methotrexate and levetiracetam resulting in delayed methotrexate elimination. Ann. Pharmacother., 2014, 48: 292–296.10.1177/106002801351195124259648Search in Google Scholar

Bauer R., Ortler M., Seiz-Rosenhagen M. et al.:Treatment of epileptic seizures in brain tumors: a critical review. Neurosurg. Rev., 2014, 37: 381–388.10.1007/s10143-014-0538-624760366Search in Google Scholar

Baxter K., Preston C.L. (eds):Stockleys Drug Interactions. 10^th ed., Pharmaceutical Press, London–Chicago 2013.Search in Google Scholar

Berg A.T., Berkovic S.F., Brodie M.J., Buchhalter J., Cross J.H., van Emde Boas W. et al.:Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE commission on classification and terminology, 2005–2009. Epilepsia, 2010, 51: 676–685.10.1111/j.1528-1167.2010.02522.x20196795Search in Google Scholar

Blümcke I.:Epilepsy-associated brain tumors. In: H. Stefan and W.H. Theodore (eds), Handbook of clinical neurology. Epilepsy. part II. 3^rd series, Elsevier, Amsterdam 2012, vol. 108: 559–568.10.1016/B978-0-444-52899-5.00015-022939053Search in Google Scholar

Bobustuc G.C., Baker C.H., Limaye A., Jenkins W.D., Pearl G. , Avgeropoulos N.G. et al.:Levetiracetam enhancesp53-me-diated MGMT inhibition and sensitizes glioblastoma cells to temozolomide. Neuro-Oncol., 2010, 12: 917–927.10.1093/neuonc/noq044294069620525765Search in Google Scholar

Boehling N.S., Sulman E.P.:Outcomes of patients with glioblastoma receiving concurrent radiation treatment and antiepileptic agents with histone deacetylase inhibitor activity. Cancer Network (http://www.cancernetwork.com), April 30, 2015.Search in Google Scholar

Boehmerle W., Huehnchen P., Endres M.:Neurologische Ne-benwirkungen von Zytostatika. Akt. Neurol., 2014, 41: 21–34.10.1055/s-0033-1363987Search in Google Scholar

Bourg V., Lebrun C., Chichmanian R.M., Thomas P., Fre-nay M.:Nitrosurea-cisplatin based chemotherapy associated with valproate: increase of haematologic toxicity. Ann. Oncol., 2001, 12: 217–219.10.1023/A:1008331708395Search in Google Scholar

Brackenbury W.J., Nelson M., Yang M., Dowle A.A., Thomas J.R. et al.:Targeting voltage-gated sodium channels with the antiepileptic drug phenytoin inhibits breast tumor growth and metastasis. Cancer Res., 2015, 75 (9 Suppl. S), P6-03-10.10.1158/1538-7445.SABCS14-P6-03-10Search in Google Scholar

Brogna Ch, Robles G., Duffau H .:Brain tumors and epilepsy. Expert Rev. Neurother., 2008, 8: 941–955.10.1586/14737175.8.6.94118505359Search in Google Scholar

Bruna J., Miro J., Roser V.:Epilepsy in glioblastoma patients: basic mechanisms and current problems in treatment. Expert Rev. Clin. Pharmacol., 2013, 6: 333–344.10.1586/ecp.13.1223656344Search in Google Scholar

Buckingham S.C., Campbell S.L., Haas B.R., Montana V., Robel St., Ogunrinu T. et al.:Glutamate release by primary brain tumors induces epileptic activity. Nat. Med., 2011, 17: 1269–1274.10.1038/nm.2453319223121909104Search in Google Scholar

Činčárová L., Zdráhal Z., Fajkus J.:New perspectives of valproic acid in clinical practice. Expert Opin. Investig. Drugs, 2013, 22: 1435–1447.10.1517/13543784.2013.85303724160174Search in Google Scholar

Cotterman-Hart S.:Antiepileptic drugs: First generation. In: H. B. Newton and M. Maschio (eds), Epilepsy and brain tumors. Elsevier, Amsterdam 2015, 159–169.10.1016/B978-0-12-417043-8.00011-0Search in Google Scholar

Das R.R., Artsy E., Hurwitz S., Wen P.Y., Black P., Golby A. et al.:Outcomes after discontinuation of antiepileptic drugs after surgery in patients with low grade brain tumors and meningiomas. J. Neurooncol., 2012, 107: 565–570.10.1007/s11060-011-0779-y22212850Search in Google Scholar

De Curtis M., Librizzi L., Avanzini G.:Mechanisms of focal epileptogenesis. In: H.B. Newton and M. Maschio (eds), Epilepsy and brain tumors. Elsevier, Amsterdam 2015, 101–109.10.1016/B978-0-12-417043-8.00006-7Search in Google Scholar

De Groot M., Reijneveld J.C., Aronica E., Heimans J.J.:Epilepsy in patients with a brain tumor: focal epilepsy requires forced treatment. Brain, 2012, 135: 1002–1016.10.1093/brain/awr31022171351Search in Google Scholar

de Oliveira J.A., Santana I.A., Caires I.Q.S., Caires-Lima R., Miranda V.C., Protásio B.M. et al.:Antiepileptic drug prophylaxis in primary brain tumor patients: is current practice in agreement to the consensus? J. Neurooncol., 2014, 120: 399–403.10.1007/s11060-014-1564-525085213Search in Google Scholar

Diener H.C., Weimar C., Berlit P., Deuschl G., Elger C., Gold R. et al. (eds.):Leitlinien für Diagnostik und Therapie in der Neurologie. Kap. 76, Gliome. 5. Aufl., Thieme, Stuttgart, 2012, 922–938.10.1055/b-0034-37859Search in Google Scholar

Englot D.J., Magill S.T., Han S.J., Chang E.F., Berger M.S., McDermott M.W.:Seizures in supratentorial meningioma: a systematic review and meta-analysis. J. Neurosurg., 2015, 4: 1–10.Search in Google Scholar

Fröscher W.:Drug resistant epilepsy. Epileptologia, 2012, 20: 17–23.Search in Google Scholar

Fröscher W., Kirschstein T., Rösche J.:Antiepileptikabehan-dlung bei Hirntumor-bedingten epileptischen Anfällen (Anticonvulsant therapy for brain tumor-related epilepsy). Fortschr. Neurol. Psychiat., 2014, 82: 678–690.10.1055/s-0034-138547525489755Search in Google Scholar

Gefroh-Grimes H.A., Gidal B.E.:Antiepileptic drugs in patients with malignant brain tumor: beyond seizures and pharmacokinetics. Acta Neurol. Scand., 2016, 133: 4–16.10.1111/ane.1243725996875Search in Google Scholar

Gerstner T., Teich M., Bell N., Longin E., Dempfle C.-E., Brand J. et al.:Valproate-associated coagulopathies are frequent and variable in children. Epilepsia, 2006, 47: 1136–1143.10.1111/j.1528-1167.2006.00587.x16886976Search in Google Scholar

Glantz M.J., Cole B.F., Forsyth P.A., Recht L.D., Wen P.Y., Chamberlain M.C. et al.:Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Neurology, 2000, 54: 1886–1893.10.1212/WNL.54.10.1886Search in Google Scholar

Glauser T., Ben-Menachem E., Bourgeois B., Caan A.A., Guerreiro C., Kälviäinen R. et al.:Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia, 2013, 54: 551–563.10.1111/epi.1207423350722Search in Google Scholar

Goldlust S.A., Hsu M., Lassman A.B., Panageas K.S., Avila E.K.:Seizure prophylaxis and melanoma brain metastases. J. Neurooncol., 2012; 108: 109–114.Search in Google Scholar

Goonawardena J., Marshman L.A., Drummond K.J.:Brain tumor-associated status epilepticus. J. Clin. Neurosci., 2015, 22: 29–34.10.1016/j.jocn.2014.03.03825150762Search in Google Scholar

Grenader T., Gipps M., Shavit L., Gabizon A.:Significant drug interaction: Phenytoin toxicity due to erlotinib. Lung cancer, 2007, 57: 404–406.10.1016/j.lungcan.2007.02.01117383767Search in Google Scholar

Grossman S.A., Ye X., Chamberlain M., Mikkelsen T., Batchelor T., Desideri S. et al.:Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial. J. Clin. Oncol., 2009, 27: 4155–4161.10.1200/JCO.2008.21.6895273442719636006Search in Google Scholar

Guerrini R., Rosati A., Giordano F., Genitori L., Barbara C.:The medical and surgical treatment of tumoral seizures: Current and future perspectives. Epilepsia, 2013, 54 (Suppl. 9): 84–90.10.1111/epi.1245024328879Search in Google Scholar

Guthrie G.D., Eljamel S.:Impact of particular antiepileptic drugs on the survival of patients with glioblastoma multiforme. J. Neurosurg., 2013, 118: 859–865.10.3171/2012.10.JNS1216923176328Search in Google Scholar

Hall W.A., Djalilian H.R., Nussbaum E.S., Cho K.H.:Longterm survival with metastatic cancer to the brain. Med. Oncol., 2000, 17: 279–286.10.1007/BF0278219211114706Search in Google Scholar

Happold C., Gorlia T., Chinot O., Gilbert M., Nabors B., Wick W. et al.:Does valproic acid improve survival in glioblastoma? A meta-analysis of randomized trials in newly diagnosed glioblastoma. Neuro-Oncology, 2015, 17: v10–v17. doi:10.1093/ neuonc/nov205.10.10.1093/neuonc/nov205.10Search in Google Scholar

Hemmer R.:Die Verkennung der Hirntumoren infolge psy-chischer Veränderungen. Dtsch. Med. Wschr., 1956, 81: 1305– 1308.10.1055/s-0028-111512113365396Search in Google Scholar

Hildebrand J., Lecaille C., Perennes J., Delattre J.-Y.:Epileptic seizures during follow-up of patients treated for primary brain tumors. Neurology, 2005, 65: 212–215.10.1212/01.wnl.0000168903.09277.8f16043788Search in Google Scholar

Hu A., Xu Z., Kim R.Y., Nguyen A., Lee J.W., Kesari S.:Seizure control: A secondary benefit of chemotherapeutic temozolomide in brain cancer patients. Epilepsy Res., 2011, 95: 270–272.10.1016/j.eplepsyres.2011.03.01821549564Search in Google Scholar

Ikeda H., Murakami T., Takano M., Usui T., Kihira K.:Pharmacokinetic interaction on valproic acid and recurrence of epileptic seizures during chemotherapy in an epileptic patient. Br. J. Clin. Pharmacol., 2005, 59: 593–597.10.1111/j.1365-2125.2005.02339.x188483615842559Search in Google Scholar

Iwamoto F.M., Kreisl T.N., Kim L., Duic J.P., Butman J.A., Albert P.S. et al.:Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas. Cancer, 2010, 116: 1776–1782.10.1002/cncr.24957284699720143438Search in Google Scholar

Jaeckle K.A., Ballman K., Furth A., Buckner J.C.:Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma. Neurology, 2009, 73: 1207–1213.10.1212/WNL.0b013e3181bbfeca276472419822870Search in Google Scholar

Japp A., Gielen G.H., Becker A.J.:Recent aspects of classification and epidemiology of epilepsy-associated tumors. Epilepsia, 2013, 54 (Suppl. 9): 5–11.10.1111/epi.1243624328865Search in Google Scholar

Jongeling A.C., Canoll P.D., Schevon C., Srinivasan S.:Seizure outcomes after glioma resection. Epilepsy Currents. Conference: 68^th Annual Meeting of the American Epilepsy Society, AES 2014 Seattle, WA United States. Conference Publication: 15 (pp 503–504), 2015.Search in Google Scholar

Kerkhof M., Dielemans J.C., van Breemen M.S., Zwinkels H., Walchenbach R., Taphoorn M. et al.:Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme. Neuro-Oncol., 2013, 15: 961–967.10.1093/neuonc/not057368802023680820Search in Google Scholar

Kerkhof M. and Vecht Ch.J.:Seizure characteristics and prognostic factors of gliomas. Epilepsia, 2013, 54 (Suppl. 9): 12–17.10.1111/epi.1243724328866Search in Google Scholar

Kerrigan S.:Drug treatment of epilepsy in people with brain tumors. Eur. J. Oncol., 2010, 4: 9–10.Search in Google Scholar

Khan R.B. and Omar A.:Seizure recurrence and risk factors after antiepileptic drug withdrawal in children with brain tumors. Epilepsia, 2006, 47: 375–379.10.1111/j.1528-1167.2006.00431.xSearch in Google Scholar

Kim L.G., Johnson T.L., Marson A.G., Chadwick D.W.:Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial. Lancet Neurol., 2006, 5: 317–322.10.1016/S1474-4422(06)70383-0Search in Google Scholar

Kim Y.H., Kim T., Joo J.D., Han J.H., Kim Y.J., Yun C.H. et al.:Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme. Cancer, 2015, 121: 2926–2932.10.1002/cncr.2943925975354Search in Google Scholar

Kirschstein T., Köhling R.:Animal models of tumor-associated epilepsy. J. Neurosci. Methods, 2015, Jun 16. pii: S0165-0270(15)00225-3. doi: 10.1016/j.jneumeth.2015.06.008. [Epub ahead of print].10.1016/j.jneumeth.2015.06.00826092434Search in Google Scholar

Koekkoek J.A.F., Dirven L., Heimans J.J., Postma T.J., Vos M.J., Reijneveld J.C. et al.:Seizure reduction in a low-grade glioma: More than a beneficial side effect of temozolomide. J. Neurol. Neurosurg. Psychiatry, 2015, 6: 366–373.10.1136/jnnp-2014-30813625055819Search in Google Scholar

Kong X., Guan J., Yang Y., Li Y., Ma W., Wang R.:A metaanalysis: Do prophylactic antiepileptic drugs in patients with brain tumors decrease the incidence of seizures? Clin. Neurol. Neurosurg., 2015, 134: 98–103.10.1016/j.clineuro.2015.04.01025978009Search in Google Scholar

Krämer G.:Tumorbedingte epileptische Anfälle bei Erwach-senen. Epilepsieblätter, 1999, 12: 2–6.Search in Google Scholar

Krumholz A., Wiebe S., Gronseth, G.S., Gloss D.S., Sanchez A.M., Kabir A.A. et al.:Evidence-based guideline: Management of an unprovoked first seizure in adults. Neurology, 2015, 84: 1705–1713.10.1212/WNL.0000000000001487440958125901057Search in Google Scholar

Liigant A., Haldre S., Öun A., Linnamägi Ü., Saar A., Asser T. et al.:Seizure disorders in patients with brain tumors. Europ. Neurol., 2001, 45: 46–51.10.1159/00005208911150841Search in Google Scholar

Liubinas S.V., O’Brien T.J., Moffat B.M., Drummond K.J., Morokoff A.P., Kaye A.H .:Tumor associated epilepsy and glutamate excitotoxicity in patients with gliomas. J. Clin. Neuro-sci., 2014, 21: 899–908.10.1016/j.jocn.2014.02.01224746886Search in Google Scholar

Lopez J.:Brain-tumor-related epilepsy in children. In: H.B. Newton and M. Maschio (eds.), Epilepsy and brain tumors. Elsevier, Amsterdam 2015, 65–99.10.1016/B978-0-12-417043-8.00005-5Search in Google Scholar

Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K., Burger P.C., Jouvet A. et al.:The 2007 WHO classification of tumors of the central nervous system. Acta Neuropathol., 2007, 114: 97–109.10.1007/s00401-007-0243-4192916517618441Search in Google Scholar

Luyken C., Blümcke I., Fimmers R. Urbach H., Elger C.E., Wiestler O.D. et al.:The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia, 2003, 44: 822–830.10.1046/j.1528-1157.2003.56102.x12790896Search in Google Scholar

Lynam L.M., Lyons M.K., Drazkowski J.F., Sirven J.I., Noe K.H., Zimmerman R.S. et al.:Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review. Clin. Neurol. Neurosurg., 2007, 109: 634–638.10.1016/j.clineuro.2007.05.01717601658Search in Google Scholar

Mamon H.J., Wen P.Y., Burns A.C., Loeffler J.S.:Allergic skin reactions to anticonvulsant medications in patients receiving cranial radiation therapy. Epilepsia, 1999, 40: 341–344.10.1111/j.1528-1157.1999.tb00715.x10080516Search in Google Scholar

Maschio M.:Brain tumor-related epilepsy. Curr. Neurophar-macol., 2012, 10: 124–133.10.2174/157015912800604470338650223204982Search in Google Scholar

Maschio M., Dinapoli L., Sperati F., Fabi A., Pace A., Vidiri A. et al.:Oxcarbazepine monotherapy in patients with brain tumor-related epilepsy. Open-label pilot study for assessing the efficacy, tolerability and impact on quality of life. J. Neuro-On-col., 2012, 106: 651–656.10.1007/s11060-011-0689-z21847705Search in Google Scholar

Maschio M., Newton H.B.:Brain tumor-related epilepsy: Introduction and overview. In: H.B. Newton and M. Maschio (eds.), Epilepsy and brain tumors. Elsevier, Amsterdam 2015a, 1–9.10.1016/B978-0-12-417043-8.00001-8Search in Google Scholar

Maschio M., Newton H.B.:Clinical approach to brain tumor-related epilepsy. In: H.B. Newton and M. Maschio (eds.), Epilepsy and brain tumors. Elsevier, Amsterdam etc., 2015b, 207–223.Search in Google Scholar

Meyer A., Fröscher W.:Anfallssteigernde Medikamente und Drogen. In: W Fröscher, F. Vassella, A. Hufnagel (eds.), DieEpi-lepsien. 2. Aufl., Schattauer, Stuttgart–New York 2004, 523–541.Search in Google Scholar

Moots P., Marciunas R., Eisert D., Parker R.A., Laporte K., Abou-Khalil B.:The course of seizure disorders in patients with malignant gliomas. Arch. Neurol., 1995, 52: 717–724.10.1001/archneur.1995.005403100910217619029Search in Google Scholar

Motl S., Zhuang Y., Waters Ch. M., Clinton St.:Pharmacokinetic considerations on the treatment of CNS tumors. Clin. Pharmacokinet., 2006, 45: 871–903.10.2165/00003088-200645090-0000216928151Search in Google Scholar

Neher K.-D.:Interaktionen: Beeinflussung der Serumkonzentra-tion von Antiepileptika durch andere Medikamente. In: Fröscher W, Blankenhorn V., May Th. W, Neher K.-D., Rambeck B., Steinhoff B.J.: Pharmakotherapie derEpilepsien. 4. Aufl., Schattauer, Stuttgart–New York, 2008a, 135–177.Search in Google Scholar

Neher K.-D. Interaktionen:Beeinflussung der Serumkonzen-tration von Nicht-Antiepileptika durch Antiepileptika. In: W. Fröscher, V Blankenhorn, Th.W May, K.-D. Neher, B. Rambeck, B.J. Steinhoff: Pharmakotherapie der Epilepsien. 4. Aufl., Schattauer, Stuttgart–New York, 2008b, 178–196.Search in Google Scholar

Newton H.B., Ray L.:Supportive care of brain tumor patients. In: H.B. Newton and M. Maschio (eds), Epilepsy and brain tumors. Elsevier, Amsterdam 2015, 45–63.10.1016/B978-0-12-417043-8.00004-3Search in Google Scholar

Oberndorfer S., Piribauer M., Marosi C., Lahrmann H., Hit-zenberger P., Grisold W.:P450 enzyme inducing and non-en-zyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy. J. Neurooncol., 2005, 72: 255–260.10.1007/s11060-004-2338-2Search in Google Scholar

Pallud J., Capelle L., Haberfeld G.:Tumoral epileptogenicity: how does it happen? Epilepsia, 2013, 54 (Suppl. 9): 30–34.10.1111/epi.12440Search in Google Scholar

Patsalos P.N.:Drug interactions with the newer antiepileptic drugs (AEDs) – Part 2: Pharmacokinetic andpharmacodynam-ic interactions between AEDs and drugs used to treat non-ep-ilepsy disorders. Clin. Pharmacokinet., 2013, 52: 1045–1061.10.1007/s40262-013-0088-zSearch in Google Scholar

Paulus W., Hasselblatt M.:Tumoren. In: G. Klöppel, H.H. Kreipe, W. Remmele (eds.), Pathologie, Bd. Neuropathologie. 3. Aufl. Springer, Berlin–Heidelberg, 2012, 481–549.Search in Google Scholar

Perucca E.:Optimizing antiepileptic drug treatment in tumoral epilepsy. Epilepsia, 2013, 54 (Suppl. 9): 97–104.10.1111/epi.12452Search in Google Scholar

Piotrowski A.F., Blakeley J.:Clinical management of seizures in patients with low-grade glioma. Semin. Radiat. Oncol., 2015, 25: 219–224.10.1016/j.semradonc.2015.02.009Search in Google Scholar

Plotkin S.R., Wen P.Y.:Neurologic complications of cancer therapy. Neurol. Clin., 2003, 21: 279–318.10.1016/S0733-8619(02)00034-8Search in Google Scholar

Prayson R.A.:Brain tumors in adults with medically intractable epilepsy. Am. J. Clin. Pathol., 2011, 136: 557–563.10.1309/AJCP0RBUQAQPZOUE21917677Search in Google Scholar

Pruitt A.A.:Medical management of patients with brain tumors. Curr. Treat. Options Neurol., 2011, 13: 413–426.10.1007/s11940-011-0132-y21557041Search in Google Scholar

Radhakrishnan A., Abraham M., Vilanilam G., Menon R., Menon D., Kumar H. et al.:Surgery for “Long-term epilepsy associated tumors (LEATs)”: Seizure outcome and its predictors. Clin. Neurol. Neurosurg., 2016, 141: 98–10510.1016/j.clineuro.2015.12.02026773699Search in Google Scholar

Rambeck B. and May Th.W.:Enzyminduktion in der Leber durch Antiepileptika. In: W Fröscher, V Blankenhorn, Th.W May, K.-D. Neher, B. Rambeck, B.J. Steinhoff: Pharmakothe-rapie der Epilepsien. 4. Aufl., Schattauer, Stuttgart–New York 2008, 128–130.Search in Google Scholar

Ray L., Maschio M., Newton H.B.:Antiepileptic drugs and brain tumor patients. In: H.B. Newton and M. Maschio (eds), Epilepsy and brain tumors. Elsevier, Amsterdam 2015, 195–205.10.1016/B978-0-12-417043-8.00013-4Search in Google Scholar

Reddy J.P., Dawood S., Mitchell M., Debeb B.G., Bloom E., Gonzales-Anqulo A.M. et al.:Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapy. Radiother. Oncol., 2015, 117: 308–314.10.1016/j.radonc.2015.10.009Search in Google Scholar

Reif P.S., Strik H., Rosenow F.:Therapeutisches Management bei Patienten mit tumorassoziierter Epilepsie – Pharmakothe-rapie. Z. Epileptol., 2012, 25: 104–113.10.1007/s10309-011-0217-3Search in Google Scholar

Relling M.V., Pui C.-H., Sandlund J.T., Rivera G.K., Hancock M.L., Boyett J.M. et al.:Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia. Lancet, 2000, 356: 285–290.10.1016/S0140-6736(00)02503-4Search in Google Scholar

Rösche J., Piek J., Hildebrandt G., Grossmann A., Kirschstein T., Benecke R.:Perampanel in the treatment of a patient with glioblastoma multiforme without IDH 1 mutation and without MGMT promotor methylation. Fortschr. Neurol. Psychi-at., 2015, 83: 286–289.10.1055/s-0034-139945926018396Search in Google Scholar

Rogers L.R.:Chemotherapy and immunotherapy of brain tumors: What the epileptologist must know. Epilepsia, 2013, 54 (Suppl. 9): 105–108.10.1111/epi.1245324328882Search in Google Scholar

Rossetti A.O., Stupp R.:Epilepsy in brain tumor patients. Curr. Opin. Neurol., 2010, 23: 603–609.10.1097/WCO.0b013e32833e996c20733482Search in Google Scholar

Rudà R., Bello L., Duffau H., Soffietti R.:Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. Neuro-Oncol., 2012, 14: 55–64.10.1093/neuonc/nos199348024423095831Search in Google Scholar

Rudà R., Trevisan E., Sofietti R.:Epilepsy and brain tumors. Curr. Opin. Oncol., 2010, 22: 611–620.10.1097/CCO.0b013e32833de99d20706121Search in Google Scholar

Ruggiero A., Rizzo D., Mastrangelo St., Battaglia D., Attinà G., Riccardi R. et al.:Interactions between antiepileptic and chemotherapeutic drugs in children with brain tumors: Is it time to change treatment? Pediatr. Blood Cancer, 2010, 54: 193–198.10.1002/pbc.2227619731334Search in Google Scholar

Salmaggi A., Granata T., Rigamonti A.:Pathophysiology of brain tumor-related epilepsy. In: H.B. Newton and M. Maschio (eds.), Epilepsy and brain tumors. Elsevier, Amsterdam 2015, 111–118.10.1016/B978-0-12-417043-8.00007-9Search in Google Scholar

Sayegh E.T., Fakurnejad S., Oh T., Bloch O., Parsa A.T.:Anticonvulsant prophylaxis for brain tumor surgery: determining the current best available evidence. J. Neurosurg., 2014, 121: 1139–1147.10.3171/2014.7.JNS132829Search in Google Scholar

Schiff D., Lee E.Q., Nayak L., Norden A.D., Reardon D.A., Wen P.:Medical management of brain tumors and the sequelae of treatment. Neuro-Oncol., 2015, 17: 488–504.10.1093/neuonc/nou304Search in Google Scholar

Schmidt D., Löscher W.:Uncontrolled epilepsy following discontinuation of antiepileptic drugs in seizure-free patients: a review of current clinical experience. Acta Neurol. Scand., 2005, 111: 291–300.10.1111/j.1600-0404.2005.00408.xSearch in Google Scholar

Seeck M.:Surgical treatment of tumoral temporal-lobe epilepsy. Lancet Neurol., 2003, 2: 722–723.10.1016/S1474-4422(03)00592-1Search in Google Scholar

Sherman J.H., Moldovan K., Yeoh H.K., Starke R.M., Pou-ratian N., Shaffrey M.E. et al.:Impact of temozolomide chemotherapy on seizure frequency in patients with low-grade gliomas. J. Neurosurg., 2011, 114: 1617–1621.10.3171/2010.12.JNS10160221235313Search in Google Scholar

Sirven J.I., Wingerchuk D.M., Drazkowski J.F., Lyons M.K., Zimmerman R.S.:Seizure prophylaxis in patients with brain tumors: A meta-analysis. Mayo Clin. Proc., 2004, 79: 1489–1494.10.4065/79.12.148915595331Search in Google Scholar

Spitzer M.:Chemo-Gehirn – Nebenwirkungen von Chemothe-rapie in Erleben, Denken, Fühlen und Handeln. Nervenheilkun-de, 2014, 33: 319–324.10.1055/s-0038-1633398Search in Google Scholar

Stefan H.:Hirntumoren und Epilepsien. Z. Epileptol., 2009, 22: 65–71.10.1007/s10309-009-0032-2Search in Google Scholar

Stupp R., Mason, W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J. et al.:Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med., 2005, 352: 987–996.10.1056/NEJMoa04333015758009Search in Google Scholar

Stupp R., Wong E.T., Kanner A.A., Steinberg D., Engelhard H., Heidecke V. et al.:NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality. Eur. J. Cancer., 2012, 48: 2192–2202.Search in Google Scholar

Stupp R., Wong E., Scott Ch., Taillibert S., Kanner A., Ke-sari S. et al.:Interim analysis of the EF-14 trial: A prospective, multi-center trial of NovoTTF-100A together with temozolomide compared to temozolomide alone in patients with newly diagnosed GBM. Neuro-Oncol., 2014, 16 (Suppl. 5): v1. Doi: 10.1093/neuronc/nou265.40.Search in Google Scholar

Swisher Ch.B., Doreswamy M., Gingrich K.J., Vredenburgh J.J., Kolls B.J.:Phenytoin, levetiracetam, andpregabalin in the acute management of refractory status epilepticus in patients with brain tumors. Neurocrit. Care, 2012, 16: 109–113.10.1007/s12028-011-9626-421882056Search in Google Scholar

Tanaka H., Jotoku H., Takasaki M., Ibayashi Y., Watanabe K., Takahashi M.:Effect of capecitabine therapy on the blood levels of antiepileptic drugs – report of two cases. Gan To Kagaku Ryoho., 2014, 41: 527–530.Search in Google Scholar

Tandon N. and Esquenazi Y.:Resection strategies in tumoral epilepsy: Is a lesionectomy enough? Epilepsia, 2013, 54 (Suppl. 9): 72–78.10.1111/epi.12448Search in Google Scholar

Tibussek D., Distelmaier F., Schönberger S., Göbel U., Ma-yatepek E.:Antiepileptic treatment in paediatric oncology – an interdisciplinary challenge. Klin. Pädiatr., 2006, 218: 340–349.10.1055/s-2006-942257Search in Google Scholar

Tinchon A., Oberndorfer S., Marosi C., Gleiss A., Gerolding-er A., Sax C.:Haematological toxicity of valproic acid compared to levetiracetam in patients with glioblastoma multiforme undergoing concomitant radiochemotherapy: a retrospective cohort study. J. Neurol., 2015, 262: 179–186.10.1007/s00415-014-7552-zSearch in Google Scholar

Toledo M., Sarria-Estrada S., Quintana M., Maldonado X., Martinez-Ricarte F., Rodon J. et al.:Prognostic implications of epilepsy in glioblastomas. Clin. Neurol. Neurosurg., 2015, 139: 166–171.10.1016/j.clineuro.2015.10.002Search in Google Scholar

Van Breemen M.S.M., Wilms E.B., Vecht Ch. J.:Epilepsy in patients with brain tumors: epidemiology, mechanism and management. Lancet Neurol., 2007, 6: 421–430.10.1016/S1474-4422(07)70103-5Search in Google Scholar

Van Breemen M.S.M., Wilms E.B., Vecht C.J.:Seizure control in brain tumors. In: W. Grisold and R. Soffietti (eds.), Handbook of clinical neurology. Neuro-oncology. Elsevier, Amsterdam 2012, vol. 104 (3^rd series), 381–389.10.1016/B978-0-444-52138-5.00026-8Search in Google Scholar

Van Breemen M.S.M., Rijsman R.M., Taphoorn M.J.B., Wal-chenbach R., Zwinkels H., Vecht J.C.:Efficacy of anti-epileptic drugs in patients with gliomas and seizures. J. Neurol., 2009, 256: 1519–1526.10.1007/s00415-009-5156-9Search in Google Scholar

Vecht C.J., Kerkhof M., Duran-Pena A.:Seizure prognosis in brain tumors: new insights and evidence-based management. Oncologist, 2014, 19: 751–759.10.1634/theoncologist.2014-0060Search in Google Scholar

Vecht Ch.J., and van Breemen M.:Optimizing therapy of seizures in patients with brain tumors. Neurology, 2006, 67 (Suppl. 4): S10–S13.10.1212/WNL.67.12_suppl_4.S10Search in Google Scholar

Vecht C.J., Wagner G.L., Wilms E.B .:Interactions between antiepileptic and chemotherapeutic drugs. Lancet Neurol., 2003, 2: 404–409.10.1016/S1474-4422(03)00435-6Search in Google Scholar

Vecht Ch.J. and Wilms E.B.:Seizures in low-and high-grade gliomas: current management and future outlook. Expert Rev. Anticancer Ther., 2010, 10: 663–669.10.1586/era.10.48Search in Google Scholar

Villikka K., Kivistö K.T., Mäenpää H., Joensuu H., Neuvonen PJ.:Cytochrome P450-inducing antiepileptics increase the clearance of vincristine in patients with brain tumors. Clin. Pharmacol. Ther., 1999, 66: 589–593.10.1053/cp.1999.v66.103403001Search in Google Scholar

Wallace E.M., O’Reilly M., Twomey M.:A review of the use of antiepileptic drugs in high-grade central nervous system tumors. Am. J. Hosp. Palliat. Care, 2012, 29: 618–621.10.1177/1049909111434367Search in Google Scholar

Weller M., Gorlia T., Cairncross J.G., van den Bent M.J., Mason W., Belanger K. et al.:Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma. Neurology, 2011, 77: 1156–1164.10.1212/WNL.0b013e31822f02e1Search in Google Scholar

Weller M., Stupp R., Wick W.:Epilepsy meets cancer: when, why, and what to do about it? Lancet Oncol., 2012, 13: e375– e382.10.1016/S1470-2045(12)70266-8Search in Google Scholar

Wells E.M., Gaillard W.D., Packer R.J.:Pediatric brain tumors and epilepsy. Semin. Pediatr. Neurol., 2012, 19: 3–8.10.1016/j.spen.2012.02.01022641070Search in Google Scholar

Wen P.Y., Schiff D., Kesari S., Drappatz J., Gigas D.C., Doherty L. et al.:Medical management of patients with brain tumors. J. Neurooncol., 2006, 80: 313–332.10.1007/s11060-006-9193-216807780Search in Google Scholar

Williams B.J., Suki D., Fox B.D., Pelloski C.E., Maldaun M.V., Sawaya R.E. et al.:Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications. J. Neurosurg., 2009, 111: 439–448.10.3171/2008.11.JNS0898419301968Search in Google Scholar

Wu A.S., Trinh V.T., Suki D., Graham S., Forman A., Weinberg J.S. et al.:A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors. J. Neurosurg., 2013, 118: 873–883.10.3171/2012.12.JNS111970408377323394340Search in Google Scholar

Wychowski T., Wang H., Buniak L., Henry J.C., Mohile N. et al.:Considerations in prophylaxis for tumor-associated epilepsy: prevention of status epilepticus and tolerability of newer generation AEDs. Clin. Neurol. Neurosurg., 2013, 115: 2365–2369.10.1016/j.clineuro.2013.08.02324054994Search in Google Scholar